Evidence for participation of GABAA receptors in a rat model of secondary hyperalgesia

European Journal of Pharmacology

Volumn 483, Issue 2-3, 2004, Pages 233-239

  Da Motta, Patricia G ^a   Veiga, Ana Paula C ^a   Francischi, Janetti N ^a   Tatsuo, Maria Aparecida K F ^a  

^a Campus da Pampulha   (Brazil)

Author keywords

GABAA receptor; Gabapentin; Hyperalgesia; Phenobarbital; Secondary

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BICUCULLINE; FORMALDEHYDE; GABAPENTIN; NEUROTIN; PHENOBARBITAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; EXPERIMENTAL MODEL; HYPERALGESIA; INTRINSIC SYMPATHOMIMETIC ACTIVITY; LATENT PERIOD; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RECEPTOR INTRINSIC ACTIVITY; TAIL FLICK TEST;

EID: 0346056869     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2003.10.015     Document Type: Article

References (31)

1. Andrews P.R., Johnston G.A.R. Commentary GABA agonists and antagonists. Biochem. Pharmacol. 28:1979;2697-2702.
2. Carlton S.M., Zhou S. Attenuation of formalin-induced nociceptive behaviors following local peripheral injection of gabapentin. Pain. 76:1998;201-207.
3. A receptors: evidence for the peripheral primary afferent depolarization. Neuroscience. 93:1999;713-722.
4. Ceseña R.M., Calcutt N.A. Gabapentin prevents hyperalgesia during the formalin test in diabetic rats. Neurosci. Lett. 262:1999;101-104.
5. Coderre T.J., Katz J., Vaccarino A.L., Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain. 52:1993;259-285.
6. D'Amour F.E., Smith D.L. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72:1941;74-79.
7. Dickenson A.H., Chapman V., Green G.M. The pharmacology of excitatory and inhibitory amino acid-mediated events in the transmission and modulation of pain in spinal cord. Gen. Pharmacol. 28:1997;633-638.
8. Dirig D.M., Yaksh T.L. Intrathecal baclofen and muscimol, but not midazolam, are antinociceptive using the rat-formalin model. J. Pharmacol. Exp. Ther. 275:1995;219-227.
9. Dubuisson D., Dennis S.G. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain. 4:1977;161-174.
10. Field M.J., Oles R.J., Lewis A.S., McCleary S., Hughes J., Singh L. Gabapentin (Neurotin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents. Br. J. Pharmacol. 121:1997;1513-1522.
11. Francischi J.N., Chaves C.T., Moura A.C.L., Lima A.S., Rocha O.A., Ferreira-Alves D.L., Bakhle Y.S. Selective inhibitors of cyclo-oxygenase-2 (COX-2) induce hypoalgesia in a rat paw model of inflammation. Br. J. Pharmacol. 137:2002;837-844.
12. Goa K.L., Sorkin E.M. Gabapentin: a review of its pharmacological properties and clinical potential in epilepsy. Drugs. 46:1993;409-427.
13. Gee N.S., Brown J.P., Dissanayake V.U., Offord J., Thurlow R., Woodruff G.N. The novel anticonvulsant drug, gabapentin (Neurotin), binds to the α2δ subunit of calcium channel. J. Biol. Chem. 271:1996;5768-5776.
14. Gotz E., Feuerstein T.J., Lais A., Meyer D.K. Effects of gabapentin on release of γ-aminobutyric acid from slices of rat neostriatum. Drug Res. 43:1993;636-638.
15. Gu Y., Huang L.-Y.M. Gabapentin actions on N-methyl-D-aspartate receptor channels are protein kinase C-dependent. Pain. 93:2001;85-92.
16. Malcangio M., Bowery N.G. GABA and its receptors in the spinal cord. Trends Pharmacol. Sci. 17:1996;457-462.
17. Matsumoto R.R. GABA receptors: are cellular differences reflected in function? Brain Res. Rev. 14:1989;203-225.
18. Mestre C., Pélissier T., Fialip J., Wilcox G., Eschalier A. A method to perform direct transcutaneous intrathecal injection in rats. J. Pharmacol. Toxicol. Methods. 32:1994;197-200.
19. Petroff O.A.C., Rothman D.L., Behar K.L., Lamoureux D., Mattson R.H. The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy. Ann. Neurol. 39:1993;95-99.
20. Rock D.M., Kelly K.M., Macdonald R.L. Gabapentin actions on ligand- and voltage-gated responses in cultured rodent neurons. Epilepsy Res. 16:1993;89-98.
21. Rosner H., Rubin L., Kestenbaum A. Gabapentin adjunctive therapy in neuropathic pain states. Clin. J. Pain. 12:1996;56-58.
22. Shimoyama N., Shimoyama M., Davis A.M., Inturrisi C.E., Elliot K.J. Spinal gabapentin is antinociceptive in the rat formalin test. Neurosci. Lett. 222:1997;65-67.
23. Singh L., Field M.J., Ferris P., Hunter J.C., Oles R.J., Williams R.G., Woodruff G.N. The antiepileptic agent gabapentin (Neurotin) possesses anxiolytic-like and antinociceptive actions that are reversed by D-serine. Psychopharmacology. 127:1996;1-9.
24. Stanfa L.C., Singh L., Williams R.G., Dickenson A.H. Gabapentin, ineffective in normal rats, markedly reduces C-fibre evoked responses after inflammation. Neuroreport. 8:1997;587-590.
25. Tatsuo M.A.K.F., Yokoro C.M., Salgado J.V., Pesquero S.M.S., Santana M.A.P., Francischi J.N. Hyperalgesic effect induced by barbiturates, midazolam and ethanol: pharmacological evidence for GABA-A receptor involvement. Braz. J. Biol. Res. 30:1997;251-256.
26. Taylor C.P., Gee N.S., Su T.Z., Kocsis J.D., Welty D.F., Brown J.P., Dooley D.J., Boden P., Singh L.A. A summary of mechanistic hypothesis of gabapentin pharmacology. Epilepsy Res. 29:1998;233-249.
27. Todd A.J., Mckenzie J. GABA-immunoreactive neurons in the dorsal horn of the rat spinal cord. Neuroscience. 31:1989;799-806.
28. Wiertelak E.P., Furness L.E., Horan R., Martinez J., Maier S.F., Watkins L.R. Subcutaneous formalin produces centrifugal hyperalgesia at a non-injected site via the NMDA-nitric oxide cascade. Brain Res. 619:1994;19-26.
29. Xiao W.H., Bennett G.J. Gabapentin relieves abnormal pain sensations via spinal site of action in rat model of painful peripheral neuropathy. Analgesia. 2:1996;267-273.
30. Yokoro C.M., Pesquero S.M.S., Turchett-Maia R.M.M., Francischi J.N., Tatsuo M.A.K.F. Acute phenobarbital administration induces hyperalgesia: pharmacological evidence for the involvement of supraspinal GABA-A receptors. Braz. J. Med. Biol. Res. 34:2001;397-405.
31. Zimmerman M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:1983;109-110.